Form 4: Beyond Air Executive Amir Avniel Acquires 400,000 Stock Options

Chief Business Officer of Beyond Air, Amir Avniel, reports the acquisition of 400,000 stock options with an exercise price of $1.53 on March 20, 2024.

Summary

• Amir Avniel, Chief Business Officer of Beyond Air, Inc., filed a Form 4 on March 21, 2024, reporting a transaction.
• The transaction involved the acquisition of 400,000 stock options on March 20, 2024, with an exercise price of $1.53.
• These options vest as to 25% on December 31, 2024, and the remainder in equal annual installments on December 31 of each of the three following years.
• The options expire on March 20, 2034.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard executive compensation disclosure. The acquisition of stock options can be seen as a positive sign of confidence, but it's a routine event.

Positives

• The acquisition of stock options by a key executive could signal confidence in the company's future performance.

Industry Context

Stock option grants are a common practice in the biotech industry to incentivize and retain key executives. This grant aligns with standard compensation practices.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation, particularly in growth-oriented companies like Beyond Air.
• Comparable companies in the biotech sector, such as BioNTech or Moderna, also utilize stock options as part of their executive compensation packages.
• The vesting schedule and exercise price are typical for such grants, designed to align executive interests with long-term shareholder value.

Stakeholder Impact

• The stock option grant could incentivize the executive to improve company performance, benefiting shareholders.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates